• Home
  • About Us
  • Technology
  • News
  • To Order
  • Contact
    • Careers
  • Home
  • About Us
  • Technology
  • News
  • To Order
  • Contact
    • Careers
•Kelyniam
•News
•0

Kelyniam Global Releases Financials for the period ending March 31, 2020

CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, releases financial performance for the first quarter of 2020.

Click here to access the report. 

0Shares
Previous PostKelyniam Releases 2019 Financial StatementsNext PostKelyniam Global Releases 2nd Quarter 2020 Financials – Growth in spite of Covid 19

Related Posts

•August 17, 2023•Kelyniam•News•0

Kelyniam Global Releases 2nd Quarter 2023 Financials

•May 18, 2023•Kelyniam•News•0

Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products

•March 20, 2023•Kelyniam•News•0

Kelyniam Global Announces Record Sales of $3 million in 2022 Financial Statements

Our mission at Kelyniam Global Inc. is to use additive manufacturing and rapid prototyping technology to create innovative medical products that improve peoples lives.

Contact Us

97 River Road, Collinsville, CT 06019

 (800) 280-8192

 info@kelyniam.com

Recent Articles

Kelyniam Global Releases 2nd Quarter 2023 Financials
August 17, 2023
Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products
May 18, 2023
Kelyniam Global Announces 3rd Quarter Results | Strong Results to Date and New Partner Announced
November 14, 2022

Stock Ticker

  • Loading stock data...
Copyright 2018 , Kelyniam Global Inc. All Rights Reserved.
Site by Web Pro MD